591 related articles for article (PubMed ID: 29562600)
21. Modulating Protein Phosphatase 2A Rescues Disease Phenotype in Neurodegenerative Tauopathies.
McKenzie-Nickson S; Chan J; Perez K; Hung LW; Cheng L; Sedjahtera A; Gunawan L; Adlard PA; Hayne DJ; McInnes LE; Donnelly PS; Finkelstein DI; Hill AF; Barnham KJ
ACS Chem Neurosci; 2018 Nov; 9(11):2731-2740. PubMed ID: 29920069
[TBL] [Abstract][Full Text] [Related]
22. Potassium 2-(1-hydroxypentyl)-benzoate improves memory deficits and attenuates amyloid and τ pathologies in a mouse model of Alzheimer's disease.
Peng Y; Hu Y; Xu S; Rong X; Li J; Li P; Wang L; Yang J; Wang X
J Pharmacol Exp Ther; 2014 Aug; 350(2):361-74. PubMed ID: 24893984
[TBL] [Abstract][Full Text] [Related]
23. Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy.
Takaichi Y; Chambers JK; Inoue H; Ano Y; Takashima A; Nakayama H; Uchida K
Acta Neuropathol Commun; 2020 Jun; 8(1):86. PubMed ID: 32560668
[TBL] [Abstract][Full Text] [Related]
24. Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3beta activation and caspase 3 cleavage.
Chun W; Waldo GS; Johnson GV
J Neurochem; 2007 Dec; 103(6):2529-39. PubMed ID: 17908237
[TBL] [Abstract][Full Text] [Related]
25. Dephosphorylation of abnormal sites of tau factor by protein phosphatases and its implication for Alzheimer's disease.
Ono T; Yamamoto H; Tashima K; Nakashima H; Okumura E; Yamada K; Hisanaga S; Kishimoto T; Miyakawa T; Miyamoto E
Neurochem Int; 1995 Mar; 26(3):205-15. PubMed ID: 7787767
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
[TBL] [Abstract][Full Text] [Related]
27. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
28. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
Leroy K; Ando K; Héraud C; Yilmaz Z; Authelet M; Boeynaems JM; Buée L; De Decker R; Brion JP
J Alzheimers Dis; 2010; 19(2):705-19. PubMed ID: 20110614
[TBL] [Abstract][Full Text] [Related]
29. Regulation of tau proteolysis by phosphatases.
Lee S; Shea TB
Brain Res; 2013 Feb; 1495():30-6. PubMed ID: 23159717
[TBL] [Abstract][Full Text] [Related]
30. Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation.
Sontag E; Nunbhakdi-Craig V; Sontag JM; Diaz-Arrastia R; Ogris E; Dayal S; Lentz SR; Arning E; Bottiglieri T
J Neurosci; 2007 Mar; 27(11):2751-9. PubMed ID: 17360897
[TBL] [Abstract][Full Text] [Related]
31. Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles.
Castillo-Carranza DL; Sengupta U; Guerrero-Muñoz MJ; Lasagna-Reeves CA; Gerson JE; Singh G; Estes DM; Barrett AD; Dineley KT; Jackson GR; Kayed R
J Neurosci; 2014 Mar; 34(12):4260-72. PubMed ID: 24647946
[TBL] [Abstract][Full Text] [Related]
32. Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration.
Li HL; Wang HH; Liu SJ; Deng YQ; Zhang YJ; Tian Q; Wang XC; Chen XQ; Yang Y; Zhang JY; Wang Q; Xu H; Liao FF; Wang JZ
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3591-6. PubMed ID: 17360687
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles.
Qin X; Wang Y; Paudel HK
Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077
[TBL] [Abstract][Full Text] [Related]
34. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
Ando K; Kabova A; Stygelbout V; Leroy K; Heraud C; Frédérick C; Suain V; Yilmaz Z; Authelet M; Dedecker R; Potier MC; Duyckaerts C; Brion JP
J Alzheimers Dis; 2014; 40 Suppl 1():S135-45. PubMed ID: 24614899
[TBL] [Abstract][Full Text] [Related]
35. Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy.
Matsumoto G; Matsumoto K; Kimura T; Suhara T; Higuchi M; Sahara N; Mori N
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772786
[TBL] [Abstract][Full Text] [Related]
36. Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer's disease.
Chu J; Lauretti E; Praticò D
Mol Psychiatry; 2017 Jul; 22(7):1002-1008. PubMed ID: 28138159
[TBL] [Abstract][Full Text] [Related]
37. The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties.
Matsumoto SE; Motoi Y; Ishiguro K; Tabira T; Kametani F; Hasegawa M; Hattori N
Hum Mol Genet; 2015 Nov; 24(22):6403-16. PubMed ID: 26374846
[TBL] [Abstract][Full Text] [Related]
38. Tau therapeutic strategies for the treatment of Alzheimer's disease.
Churcher I
Curr Top Med Chem; 2006; 6(6):579-95. PubMed ID: 16712493
[TBL] [Abstract][Full Text] [Related]
39. Long-term overexpression of heme oxygenase 1 promotes tau aggregation in mouse brain by inducing tau phosphorylation.
Hui Y; Wang D; Li W; Zhang L; Jin J; Ma N; Zhou L; Nakajima O; Zhao W; Gao X
J Alzheimers Dis; 2011; 26(2):299-313. PubMed ID: 21613741
[TBL] [Abstract][Full Text] [Related]
40. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.
Caccamo A; Magrì A; Medina DX; Wisely EV; López-Aranda MF; Silva AJ; Oddo S
Aging Cell; 2013 Jun; 12(3):370-80. PubMed ID: 23425014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
